[HTML][HTML] Genetic variations of Plasmodium falciparum circumsporozoite protein and the impact on interactions with human immunoproteins and malaria vaccine …
In October 2021, the world's first malaria vaccine RTS, S was endorsed by WHO for broad
use in children, despite its low efficacy. This study examined polyclonal infections and the …
use in children, despite its low efficacy. This study examined polyclonal infections and the …
Genetic variations of Plasmodium falciparum circumsporozoite protein and the impact on interactions with human immunoproteins and malaria vaccine efficacy.
CC Dieng, CT Ford, A Lerch, D Doniou… - … Evolution: Journal of …, 2023 - europepmc.org
In October 2021, the world's first malaria vaccine RTS, S was endorsed by WHO for broad
use in children, despite its low efficacy. This study examined polyclonal infections and the …
use in children, despite its low efficacy. This study examined polyclonal infections and the …
[PDF][PDF] Genetic variations of Plasmodium falciparum circumsporozoite protein and the impact on interactions with human immunoproteins and malaria vaccine efficacy
CC Dieng, CT Ford, A Lerch, D Doniou, K Vegesna… - media.malariaworld.org
In October 2021, the world's first malaria vaccine RTS, S was endorsed by WHO for broad
use in children, despite its low efficacy. This study examined polyclonal infections and the …
use in children, despite its low efficacy. This study examined polyclonal infections and the …
Genetic variations of Plasmodium falciparum circumsporozoite protein and the impact on interactions with human immunoproteins and malaria vaccine efficacy
CC Dieng, CT Ford, A Lerch… - Infection, genetics …, 2023 - pubmed.ncbi.nlm.nih.gov
In October 2021, the world's first malaria vaccine RTS, S was endorsed by WHO for broad
use in children, despite its low efficacy. This study examined polyclonal infections and the …
use in children, despite its low efficacy. This study examined polyclonal infections and the …
Genetic variations of Plasmodium falciparum circumsporozoite protein and the impact on interactions with human immunoproteins and malaria vaccine efficacy.
CC Dieng, CT Ford, A Lerch, D Doniou, K Vegesna… - 2023 - cabidigitallibrary.org
In October 2021, the world's first malaria vaccine RTS, S was endorsed by WHO for broad
use in children, despite its low efficacy. This study examined polyclonal infections and the …
use in children, despite its low efficacy. This study examined polyclonal infections and the …
Genetic variations of Plasmodium falciparum circumsporozoite protein and the impact on interactions with human immunoproteins and malaria vaccine efficacy
CC Dieng, CT Ford, A Lerch, D Doniou… - Infection, Genetics …, 2023 - ui.adsabs.harvard.edu
In October 2021, the world's first malaria vaccine RTS, S was endorsed by WHO for broad
use in children, despite its low efficacy. This study examined polyclonal infections and the …
use in children, despite its low efficacy. This study examined polyclonal infections and the …